Skip to main content

Advertisement

SpringerLink
Log in

Treatment of acromegaly: is there still a place for radiotherapy?

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Objective

To evaluate efficacy and safety of radiotherapy on acromegaly treatment.

Design and patients

We followed retrospectively 99 acromegalic patients for at least one year after radiotherapy (RT). RT had been performed after unsuccessful surgery in 91 patients and as primary treatment in eight. Time elapsed between surgery and RT was 1.4 ± 2.4 years. Mean follow-up after RT was 5.9 ± 4.7 years (1–16 years). All patients were treated with linear accelerator, 89 by conventional (3240–6000 cGY) and ten by stereotactic RT.

Measurements

Biochemical remission was defined as GH < 2.5 ng/ml and IGF-I normalization.

Results

At latest follow-up, 54% of patients had serum GH level <2.5 ng/ml; 42% had normal IGF-I and 38% of patients achieved normalization of both. Controlled patients had lower baseline GH and IGF-I levels compared to uncontrolled ones. They achieved remission after 3.8 ± 2.4 years, a significantly lower time length compared to maximum follow-up of uncontrolled (6.0 ± 4.9 year). Results regarding GH and IGF-I levels were similar in patients treated either primarily or after surgery. No patient showed tumor growth. Visual field defects were observed in four, seizures in one, and mental disorders in two patients, although cognitive function were not properly assessed. At the last follow-up, 47% of patients had acquired at least one hormonal deficiency.

Conclusions

There is still a place for RT in acromegaly treatment, mainly for: after non-curative surgery and poor response or inaccessibility to medical treatment; growth restraining of aggressive macroadenomas; co-morbidities that contraindicate surgery and surgery refusal. However, side effects and latency period to achieve disease control should be kept in mind.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP, Bertherat J (2000) Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85:3779–3785

    Article  PubMed  CAS  Google Scholar 

  2. Biermasz NR, van Dulken H, Roelfsema F (2000) Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 85:2476–2482

    Article  PubMed  CAS  Google Scholar 

  3. Powell JS, Wardlaw SL, Post KD, Freda PU (2000) Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab 85:2068–2071

    Article  PubMed  CAS  Google Scholar 

  4. Epaminonda P, Porretti S, Cappiello V, Beck-Peccoz P, Faglia G, Arosio M (2001) Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. Clin Endocrinol (Oxf) 55:183–189

    Article  CAS  Google Scholar 

  5. Minniti G, Jaffrain-Rea ML, Osti M, Esposito V, Santoro A, Solda F, Gargiulo P, Tamburrano G, Enrici RM (2005) The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 62:210–216

    Article  Google Scholar 

  6. Swords FM, Allan CA, Plowman PN, Sibtain A, Evanson J, Chew SL, Grossman AB, Besser GM, Monson JP ( 2003) Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas. J Clin Endocrinol Metab 88:5334–5340

    Article  PubMed  CAS  Google Scholar 

  7. Wright AD, Hill DM, Lowy C, Fraser TR (1970) Mortality in acromegaly. Q J Med 39:1–16

    PubMed  CAS  Google Scholar 

  8. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12:71–79

    CAS  Google Scholar 

  9. Bengtsson BA, Eden S, Ernest I, Oden A, Sjögren B (1988) Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327–335

    Article  PubMed  CAS  Google Scholar 

  10. Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667–674

    Article  PubMed  CAS  Google Scholar 

  11. Littley MD, Shalet SM, Swindell R, Beardwell CG, Sutton ML (1990) Low-dose pituitary irradiation for acromegaly. Clin Endocrinol (Oxf) 32:261–270

    CAS  Google Scholar 

  12. Jenkins D, O’Brien I, Johnson A, Shakespear R, Sheppard MC, Stewart PM (1995) The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly. Clin Endocrinol (Oxf) 43:517–522

    CAS  Google Scholar 

  13. Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 91:1239–1245

    Article  PubMed  CAS  Google Scholar 

  14. Speirs CJ, Reed PI, Morrison R, Aber V, Joplin GF (1990) The effectiveness of external beam radiotherapy for acromegaly is not affected by previous pituitary ablative treatments. Acta Endocrinologica 122:559–565

    PubMed  CAS  Google Scholar 

  15. Sheehan JP, Jagannathan J, Pouratian N, Steiner L (2006) Stereotactic radiosurgery for pituitary adenomas: a review of the literature and our experience. Front Horm Res 34:185–205

    PubMed  Google Scholar 

  16. Gutt B, Wowra B, Alexandrov R, Uhl E, Schaaf L, Stalla GK, Schopohl J (2005) Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Exp Clin Endocrinol Diabetes 113:219–224

    Article  PubMed  CAS  Google Scholar 

  17. Laws ER, Sheehan JP, Sheehan JM, Jagnathan J, Jane JAJ, Oskouian R (2004) Stereotactic radiosurgery for pituitary adenomas: a review of the literature. J Neurooncol 69:257–272

    Article  PubMed  Google Scholar 

  18. Jezkova J, Marek J, Hana V, Krsek M, Weiss V, Vladyka V, Lisak R, Vymazal J, Pecen L (2006) Gamma knife radiosurgery for acromegaly–long-term experience. Clin Endocrinol (Oxf) 64:588–595

    Article  Google Scholar 

  19. Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF Sandler HM (1997) Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 82:3187–3191

    Article  PubMed  CAS  Google Scholar 

  20. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (1998) Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 88:1002–1008

    Article  PubMed  CAS  Google Scholar 

  21. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (2000) Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85:1287–1289

    Article  PubMed  CAS  Google Scholar 

  22. Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, Conte-Devolx B, Regis J, Dufour H, Brue T (2005) Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 90:4483–4488

    Article  PubMed  CAS  Google Scholar 

  23. Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander E 3rd, Kooy HM, Flickinger JC (1993) Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27:215–221

    PubMed  CAS  Google Scholar 

  24. Girkin CA, Comey CH, Lunsford LD, Goodman ML, Kline LB (1997) Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology 104:1634–1643

    PubMed  CAS  Google Scholar 

  25. Dowsett RJ, Fowble B, Sergott RC, Savino PJ, Bosley TM, Snyder PJ, Gennarelli TA (1990) Results of radiotherapy in the treatment of acromegaly: lack of ophthalmologic complications. Int J Radiat Oncol Biol Phys 19:453–459

    PubMed  CAS  Google Scholar 

  26. Movsas B, Movsas TZ, Steinberg SM, Okunieff P (1995) Long-term visual changes following pituitary irradiation. Int J Radiat Oncol Biol Phys 33:599–605

    Article  PubMed  CAS  Google Scholar 

  27. Bhansali A, Banerjee AK, Chanda A, Singh P, Sharma SC, Mathuriya SN, Dash RJ (2004) Radiation-induced brain disorders in patients with pituitary tumors Australas Radiol 48:339–346

    Google Scholar 

  28. Jones B, Samarasekara S, Tan LT, Mayles WP (1996) The influence of air cavities on the optic chiasm dose during pituitary radiotherapy for acromegaly. Br J Radiol 69:723–725

    Article  PubMed  CAS  Google Scholar 

  29. Erfurth EM, Bulow B, Mikoczy Z, Svahn-Tapper G, Hagmar L (2001) Is there an increase in second brain tumors after surgery and irradiation for a pituitary tumour? Clin Endocrinol (Oxf) 55:613–616

    Article  CAS  Google Scholar 

  30. Bliss P, Kerr GR, Gregor A (1994) Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962–1990. Clin Oncol (R Coll Radiol) 6:361–363

    CAS  Google Scholar 

  31. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, Rajan B, Traish D (1992) Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. Br Med J 304:1343–1346

    Article  CAS  Google Scholar 

  32. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ (1994) Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30:557–565

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hosp. Das Clin./Univ. Sao Paolo, Sao Paolo, Brazil

    Raquel S. Jallad, Nina R. Musolino, Luiz R. Salgado & Marcello D. Bronstein

Authors
  1. Raquel S. Jallad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nina R. Musolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luiz R. Salgado
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcello D. Bronstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcello D. Bronstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jallad, R.S., Musolino, N.R., Salgado, L.R. et al. Treatment of acromegaly: is there still a place for radiotherapy?. Pituitary 10, 53–59 (2007). https://doi.org/10.1007/s11102-007-0002-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-007-0002-5

Keywords

Search

Navigation